Product Information
CYMBALTA 30 MG CAPSULE is a brand product labeled by Eli Lilly and Company, priced at $8.9665 per EA under NDC 00002324090. Its NADAC has been published 647 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Duloxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Eli Lilly and CompanyNDC
00002324090
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
7/23/2025
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021427On Market Since
8/24/2004
Pharmacological Classes
Price Statistics
The NADAC for CYMBALTA 30 MG CAPSULE has been published 647 times since Nov 28, 2013, and over the history we have for it it has risen 27.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9665 per EA |
|---|---|
| All-time high | $8.9831 (Apr 10, 2024) |
| All-time low | $6.9035 (Sep 20, 2017) |
| 52-week high | $8.9730 |
| 52-week low | $8.9665 |
| Median price | $8.0210 |
| Average price | $8.0197 |
| Largest weekly change | +9.9% (Dec 27, 2017) |
| Weeks tracked | 647 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYMBALTA 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYMBALTA 30 MG CAPSULE, manufactured by Eli Lilly and Company, is $8.9665 per EA (NDC 00002324090), effective Apr 15, 2026.
How has the price of CYMBALTA 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYMBALTA 30 MG CAPSULE has risen 27.1%. It has been tracked across 647 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYMBALTA 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CYMBALTA 30 MG CAPSULE has ranged from a low of $6.9035 (Sep 20, 2017) to a high of $8.9831 (Apr 10, 2024), with a median of $8.0210 per EA.
Are there cheaper alternatives to CYMBALTA 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CYMBALTA 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CYMBALTA 30 MG CAPSULE?
CYMBALTA 30 MG CAPSULE (NDC 00002324090) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification